Patents Assigned to New Vision Co., Ltd.
  • Composition for prophylaxis and/or treatment of dry eye syndrome comprising vitamin D
    Patent number: 6410006
    Abstract: An ophthalmic composition for prophylaxis and/or treatment of keratoconjunctivitis sicca, which is locally administered to the eyes and which comprises, as an effective component, at least one member selected from the group consisting of vitamin D, active vitamin D, and active vitamin D analogues.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: June 25, 2002
    Assignee: New Vision Co., Ltd.
    Inventors: Seiji Itoh, Yasuo Ishii, Katsuhiko Mukai, Kiyoshi Kita
  • Composition for prophylaxis and/or treatment of dry eye syndrome comprising vitamin D
    Publication number: 20010027188
    Abstract: An ophthalmic composition for prophylaxis and/or treatment of keratoconjunctivitis sicca, which is locally administered to the eyes and which comprises, as an effective component, at least one member selected from the group consisting of vitamin D, active vitamin D, and active vitamin D analogues.
    Type: Application
    Filed: February 16, 2001
    Publication date: October 4, 2001
    Applicant: NEW VISION CO., LTD.
    Inventors: Seiji Itoh, Yasuo Ishii, Katsuhiko Mukai, Kiyoshi Kita
  • Composition for prophylaxis and/or treatment of dry syndrome comprising vitamin D
    Patent number: 6187331
    Abstract: An ophthalmic composition for prophylaxis and/or treatment of keratoconjunctivitis sicca, which is locally administered to the eyes and which comprises, as an effective component, at least one member selected from the group consisting of vitamin D, active vitamin D, and active vitamin D analogues.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: February 13, 2001
    Assignee: New Vision Co., Ltd.
    Inventors: Seiji Itoh, Yasuo Ishii, Katsuhiko Mukai, Kiyoshi Kita
  • Ophthalmic composition containing active Vitamin D
    Patent number: 5876709
    Abstract: An ophthalmic composition for preventing corneal haze and corneal refraction anomaly observed after anterior ocular tissues are damaged or during corneal diseases comprises, as an effective component, vitamin D such as ergocalciferols and cholecalciferols or active vitamin D.
    Type: Grant
    Filed: May 27, 1997
    Date of Patent: March 2, 1999
    Assignee: New Vision Co., Ltd.
    Inventors: Seiji Itoh, Yasuo Ishii, Katsuhiko Mukai, Kiyoshi Kita
  • Method and composition for treating cataracts
    Patent number: 4778828
    Abstract: A non-toxic pharmaceutical composition which when applied to a patient with cataracts through preferably intravenous injection on a consecutive daily basis for a predetermined time period based upon the severity of the cataracts will serve to dissolve all the cataract and thereby restore commensurate lost vision to the patient due to the formation and presence of the cataract.
    Type: Grant
    Filed: July 31, 1987
    Date of Patent: October 18, 1988
    Assignee: New Vision Co. Ltd.
    Inventors: Zolton Palmai, Gyula Nagy